Literature DB >> 19877107

Out-of-pocket expenses and their burden in patients with rheumatoid arthritis.

Frederick Wolfe1, Kaleb Michaud.   

Abstract

OBJECTIVE: To describe and understand the burden of out-of-pocket expenses in patients with rheumatoid arthritis (RA).
METHODS: We studied out-of-pocket expenses and their burden in 8,545 US patients with RA. We determined direct medical costs, out-of-pocket expenses, the burden of out-of-pocket expenses, household income, and measures of RA severity and outcome. In addition, patients were classified into 3 groups based on the level of burden caused by out-of-pocket expenses: no or limited problem (I am able to pay the bills without much problem); moderate problem (paying the bills takes away some money I need for other activities); and a great problem (I can't purchase all of the medications or medical care that I need).
RESULTS: A total of 43.6% of patients reported problems paying medical bills after insurance payments and 9.0% reported severe or great problems. Problems with expenses were associated with measures of RA severity, but also and particularly with lower household income and absence of health insurance. The proportion of household income that was consumed by out-of-pocket spending for the 3 groups was 2.4%, 7.2%, and 19.2%, respectively, and the percentage of patients meeting the 185% poverty level for these groups was 12.3%, 24.4%, and 51.3%, respectively.
CONCLUSION: The out-of-pocket burden is substantial, particularly in those <65 years of age. Out-of-pocket expenses exert their severity predominantly on those with the most severe RA who have the least ability to pay. Household income is the primary determinant of out-of-pocket burden, followed by RA severity, and type of health insurance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19877107     DOI: 10.1002/art.24724

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  10 in total

Review 1.  Racial and ethnic disparities in rheumatoid arthritis.

Authors:  Christine A McBurney; Ernest R Vina
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

2.  Medical Care Costs Associated With Rheumatoid Arthritis in the US: A Systematic Literature Review and Meta-Analysis.

Authors:  Andrew Hresko; Tzu-Chieh Lin; Daniel H Solomon
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-10       Impact factor: 4.794

3.  What Strategies Do Physicians and Patients Discuss to Reduce Out-of-Pocket Costs? Analysis of Cost-Saving Strategies in 1,755 Outpatient Clinic Visits.

Authors:  Wynn G Hunter; Cecilia Z Zhang; Ashley Hesson; J Kelly Davis; Christine Kirby; Lillie D Williamson; Jamison A Barnett; Peter A Ubel
Journal:  Med Decis Making       Date:  2016-01-19       Impact factor: 2.583

4.  Sociodemographic Determinants of Out-of-Pocket Expenditures for Patients Using Prescription Drugs for Rheumatoid Arthritis.

Authors:  Kumar Mukherjee; Khalid M Kamal
Journal:  Am Health Drug Benefits       Date:  2017-02

5.  Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey.

Authors:  Yuko Kodama; Ryoko Morozumi; Tomoko Matsumura; Yukiko Kishi; Naoko Murashige; Yuji Tanaka; Morihito Takita; Nobuyo Hatanaka; Eiji Kusumi; Masahiro Kami; Akihiko Matsui
Journal:  BMC Cancer       Date:  2012-04-24       Impact factor: 4.430

6.  Design of a phase IV randomised, double-blind, placebo-controlled trial assessing the ImPact of Residual Inflammation Detected via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) patients (PREDICTRA).

Authors:  Paul Emery; Gerd R Burmester; Esperanza Naredo; Yijie Zhou; Maja Hojnik; Philip G Conaghan
Journal:  BMJ Open       Date:  2018-02-28       Impact factor: 2.692

7.  Impact of assessing patient-reported outcomes with mobile apps on patient-provider interaction.

Authors:  Yomei Shaw; Delphine S Courvoisier; Almut Scherer; Adrian Ciurea; Thomas Lehmann; Veronika K Jaeger; Ulrich A Walker; Axel Finckh
Journal:  RMD Open       Date:  2021-04

Review 8.  Racial, ethnic, and healthcare disparities in rheumatoid arthritis.

Authors:  Kevin Yip; Iris Navarro-Millán
Journal:  Curr Opin Rheumatol       Date:  2021-03-01       Impact factor: 4.941

Review 9.  The Autoimmune Ecology.

Authors:  Juan-Manuel Anaya; Carolina Ramirez-Santana; Maria A Alzate; Nicolas Molano-Gonzalez; Adriana Rojas-Villarraga
Journal:  Front Immunol       Date:  2016-04-26       Impact factor: 7.561

10.  Patient-physician discussions about costs: definitions and impact on cost conversation incidence estimates.

Authors:  Wynn G Hunter; Ashley Hesson; J Kelly Davis; Christine Kirby; Lillie D Williamson; Jamison A Barnett; Peter A Ubel
Journal:  BMC Health Serv Res       Date:  2016-03-31       Impact factor: 2.655

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.